BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 29471331)

  • 1. Cross Cultural Validation and Extension of the Clinical Assessment Interview for Negative Symptoms (CAINS) in the Chinese Context: Evidence from a Spectrum Perspective.
    Xie DJ; Shi HS; Lui SSY; Shi C; Li Y; Ho KKY; Hung KSY; Li WX; Yi ZH; Cheung EFC; Kring AM; Chan RCK
    Schizophr Bull; 2018 Oct; 44(suppl_2):S547-S555. PubMed ID: 29471331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing negative symptoms in schizophrenia: Validity of the clinical assessment interview for negative symptoms in Singapore.
    Rekhi G; Ang MS; Yuen CKY; Ng WY; Lee J
    Schizophr Res; 2019 Apr; 206():177-182. PubMed ID: 30558979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation and extension of the Motivation and Pleasure Scale-Self Report (MAP-SR) across the schizophrenia spectrum in the Chinese context.
    Wang LL; Ma EPY; Lui SSY; Cheung EFC; Cheng KS; Chan RCK
    Asian J Psychiatr; 2020 Mar; 49():101971. PubMed ID: 32065963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation.
    Kring AM; Gur RE; Blanchard JJ; Horan WP; Reise SP
    Am J Psychiatry; 2013 Feb; 170(2):165-72. PubMed ID: 23377637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the German version of the Clinical Assessment Interview for Negative Symptoms (CAINS).
    Engel M; Fritzsche A; Lincoln TM
    Psychiatry Res; 2014 Dec; 220(1-2):659-63. PubMed ID: 25138895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for two distinct domains of negative symptoms: Confirming the factorial structure of the CAINS.
    Richter J; Hesse K; Schreiber L; Burmeister CP; Eberle MC; Eckstein KN; Zimmermann L; Wildgruber D; Klingberg S
    Psychiatry Res; 2019 Jan; 271():693-701. PubMed ID: 30791343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining the reliability and validity of the Clinical Assessment Interview for Negative Symptoms within the Management of Schizophrenia in Clinical Practice (MOSAIC) multisite national study.
    Blanchard JJ; Bradshaw KR; Garcia CP; Nasrallah HA; Harvey PD; Casey D; Csoboth CT; Hudson JI; Julian L; Lentz E; Nuechterlein KH; Perkins DO; Skale TG; Snowden LR; Tandon R; Tek C; Velligan D; Vinogradov S; O'Gorman C
    Schizophr Res; 2017 Jul; 185():137-143. PubMed ID: 28087270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the Spanish version of the Clinical Assessment for Negative Symptoms (CAINS).
    Valiente-Gómez A; Mezquida G; Romaguera A; Vilardebò I; Andrés H; Granados B; Larrubia J; Pomarol-Clotet E; McKenna PJ; Sarró S; Bernardo M
    Schizophr Res; 2015 Aug; 166(1-3):104-9. PubMed ID: 26116328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and psychometric validation of the Clinical Assessment Interview for Negative Symptoms (CAINS).
    Horan WP; Kring AM; Gur RE; Reise SP; Blanchard JJ
    Schizophr Res; 2011 Nov; 132(2-3):140-5. PubMed ID: 21798716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial development and preliminary validation of a new negative symptom measure: the Clinical Assessment Interview for Negative Symptoms (CAINS).
    Forbes C; Blanchard JJ; Bennett M; Horan WP; Kring A; Gur R
    Schizophr Res; 2010 Dec; 124(1-3):36-42. PubMed ID: 20869848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-assessment of negative symptoms - Critical appraisal of the motivation and pleasure - Self-report's (MAP-SR) validity and reliability.
    Richter J; Hesse K; Eberle MC; Eckstein KN; Zimmermann L; Schreiber L; Burmeister CP; Wildgruber D; Klingberg S
    Compr Psychiatry; 2019 Jan; 88():22-28. PubMed ID: 30466014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Korean-Version of the Clinical Assessment Interview for Negative Symptoms of Schizophrenia (CAINS).
    Jung SI; Woo J; Kim YT; Kwak SG
    J Korean Med Sci; 2016 Jul; 31(7):1114-20. PubMed ID: 27366011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometric Characteristics of the Macedonian Version of Clinical Assessment Interview for Negative Symptoms (CAINS).
    Blaževska Stoilkovska B; Bajraktarov S; Markovska Simoska S; Milutinović M; Novotni L; Arsova S; Novotni G; Čalovska Samardziska V; Delova S; Novotni A; Jovanović N
    Psychiatr Danub; 2021; 33(3):347-353. PubMed ID: 34795177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motivation and Pleasure Scale-Self-Report (MAP-SR): Validation of the German version of a self-report measure for screening negative symptoms in schizophrenia.
    Engel M; Lincoln TM
    Compr Psychiatry; 2016 Feb; 65():110-5. PubMed ID: 26773998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A blinded validation of the Swedish version of the Clinical Assessment Interview for Negative Symptoms (CAINS).
    Bengtsson J; Bodén R; Neider D; Cernvall M
    Nord J Psychiatry; 2022 Jan; 76(1):44-51. PubMed ID: 34126848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Psychometric Comparison of the Clinical Assessment Interview for Negative Symptoms and the Brief Negative Symptom Scale.
    Strauss GP; Gold JM
    Schizophr Bull; 2016 Nov; 42(6):1384-1394. PubMed ID: 27174556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for negative symptoms: preliminary results from the self-report version of the Clinical Assessment Interview for Negative Symptoms.
    Park SG; Llerena K; McCarthy JM; Couture SM; Bennett ME; Blanchard JJ
    Schizophr Res; 2012 Mar; 135(1-3):139-43. PubMed ID: 22265640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Latent Structure of Negative Symptoms in Schizophrenia.
    Strauss GP; Nuñez A; Ahmed AO; Barchard KA; Granholm E; Kirkpatrick B; Gold JM; Allen DN
    JAMA Psychiatry; 2018 Dec; 75(12):1271-1279. PubMed ID: 30208377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Motivation and Pleasure Scale-Self-Report (MAP-SR): reliability and validity of a self-report measure of negative symptoms.
    Llerena K; Park SG; McCarthy JM; Couture SM; Bennett ME; Blanchard JJ
    Compr Psychiatry; 2013 Jul; 54(5):568-74. PubMed ID: 23351831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experiential pleasure deficits in different stages of schizophrenia.
    Li Z; Lui SS; Geng FL; Li Y; Li WX; Wang CY; Tan SP; Cheung EF; Kring AM; Chan RC
    Schizophr Res; 2015 Aug; 166(1-3):98-103. PubMed ID: 26072322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.